All Stories

  1. Empagliflozin improves metabolism and prevents myocardial and coronary dysfunction in streptozotocin-diabetic and non-diabetic rats subjected to ischemia/reperfusion
  2. Corrigendum “Empagliflozin mitigates ponatinib-induced cardiotoxicity by restoring the connexin 43-autophagy pathway” [Biomed. Pharmacother. 178 (2024), 117278]
  3. CLIP2: a novel functional player in AQP5 trafficking dynamics and implications for Sjögren’s disease
  4. Identification of Connexin 26 on Extracellular Vesicles from Human Cardiomyocytes and Plasma: Novel Insights into miRNA Loading and Oxidative Injury
  5. Identification of Connexin 26 on Extracellular Vesicles from Human Cardiomyocytes and Plasma: Novel Insights into miRNA Loading and Oxidative Injury
  6. Ultrastructural and Molecular Analysis of Vascular Smooth Muscle Cells During the Switch from a Physiological to a Pathological Phenotype
  7. Dopamine-mediated autocrine inhibition of insulin secretion
  8. Empagliflozin mitigates ponatinib-induced cardiotoxicity by restoring the connexin 43-autophagy pathway
  9. Cardiovascular outcomes and molecular targets for the cardiac effects of Sodium-Glucose Cotransporter 2 Inhibitors: A systematic review
  10. Empagliflozin restores autophagy and attenuates ponatinib-induced cardiomyocyte senescence and death
  11. Effect of Combined Levothyroxine (L-T4) and 3-Iodothyronamine (T1AM) Supplementation on Memory and Adult Hippocampal Neurogenesis in a Mouse Model of Hypothyroidism
  12. Empagliflozin inhibits excessive autophagy through the AMPK/GSK3β signalling pathway in diabetic cardiomyopathy
  13. Connexin Expression in Human Minor Salivary Glands: An Immunohistochemical Microscopy Study
  14. Dysregulated insulin secretion is associated with pancreatic β‐cell hyperplasia and direct acinar‐β‐cell trans‐differentiation in partially eNOS ‐deficient mice
  15. Sex‐related differential susceptibility to ponatinib cardiotoxicity and differential modulation of the Notch1 signalling pathway in a murine model
  16. Sodium-glucose cotransporter type 2 inhibitors prevent ponatinib-induced endothelial senescence and disfunction: A potential rescue strategy
  17. Subcellular Localization of Connexin 26 in Cardiomyocytes and in Cardiomyocyte-Derived Extracellular Vesicles
  18. September 30—October 3, 2021 Virtual
  19. Ezrin Is a Novel Protein Partner of Aquaporin-5 in Human Salivary Glands and Shows Altered Expression and Cellular Localization in Sjögren’s Syndrome
  20. Unraveling Human AQP5-PIP Molecular Interaction and Effect on AQP5 Salivary Glands Localization in SS Patients
  21. Connexin 43 and Connexin 26 Involvement in the Ponatinib-Induced Cardiomyopathy: Sex-Related Differences in a Murine Model
  22. Delivery of Thyronamines (TAMs) to the Brain: A Preliminary Study
  23. Nanoparticles Based on Quaternary Ammonium Chitosan-methyl-β-cyclodextrin Conjugate for the Neuropeptide Dalargin Delivery to the Central Nervous System: An In Vitro Study
  24. Heart and liver connexin expression related to the first stage of aging: A study on naturally aged animals
  25. Aging and biomarkers: Transcriptional levels evaluation of Osteopontin/miRNA-181a axis in hepatic tissue of rats in different age ranges
  26. Evaluation of transcriptional levels of the natriuretic peptides, endothelin-1, adrenomedullin, their receptors and long non-coding RNAs in rat cardiac tissue as cardiovascular biomarkers of aging
  27. Localization of Histidine-rich Glycoprotein (HRG) in skeletal muscle
  28. The WNT Pathway Is Relevant for the BCR-ABL1-Independent Resistance in Chronic Myeloid Leukemia
  29. Phenotyping multiple subsets in Sjögren’s syndrome: a salivary proteomic SWATH-MS approach towards precision medicine
  30. Matrix metalloproteinase inhibitors prevent the release and proteolytic activity of monocyte/macrophage-derived microparticles
  31. Rho-inhibition and neuroprotective effect on rotenone-treated dopaminergic neurons in vitro
  32. Nutlin-loaded magnetic solid lipid nanoparticles for targeted glioblastoma treatment
  33. The Polycomb BMI1 Protein Is Co-expressed With CD26+ in Leukemic Stem Cells of Chronic Myeloid Leukemia
  34. Connexin 26 Expression in Mammalian Cardiomyocytes
  35. Ex Vivo and in Vivo Study of Sucrosomial® Iron Intestinal Absorption and Bioavailability
  36. Immunohistochemical localization of histidine-rich glycoprotein in human skeletal muscle: preferential distribution of the protein at the sarcomeric I-band
  37. Nanoparticles based on quaternary ammonium–chitosan conjugate: A vehicle for oral administration of antioxidants contained in red grapes
  38. Salbutamol inhibits RhoA activation in normal but not in desensitized bronchial smooth muscle cells
  39. Adenosine Receptor Transcriptomic Profile in Cardiac Tissue of a Zucker Rat Model
  40. Altered expression of connexin 43 and related molecular partners in a pig model of left ventricular dysfunction with and without dipyrydamole therapy
  41. High concentration of C-type natriuretic peptide promotes VEGF-dependent vasculogenesis in the remodeled region of infarcted swine heart with preserved left ventricular ejection fraction
  42. Impact of Obesity on the Expression Profile of Natriuretic Peptide System in a Rat Experimental Model
  43. Adenosine receptor expression in an experimental animal model of myocardial infarction with preserved left ventricular ejection fraction
  44. Altered Expression Pattern of Molecular Factors Involved in Colonic Smooth Muscle Functions: An Immunohistochemical Study in Patients with Diverticular Disease
  45. Histopathology in Gastrointestinal Neuromuscular Diseases
  46. Regional evidence of modulation of cardiac adiponectin level in dilated cardiomyopathy: pilot study in a porcine animal model
  47. Pacing-Induced Regional Differences in Adenosine Receptors mRNA Expression in a Swine Model of Dilated Cardiomyopathy
  48. Immunohistochemical analysis of myenteric ganglia and interstitial cells of Cajal in ulcerative colitis
  49. Expression of C-type natriuretic peptide and its receptor NPR-B in cardiomyocytes
  50. Effect of Laser Micromachining of Titanium on Viability and Responsiveness of Osteoblast-Like Cells
  51. Evidence that muscle cells do not express the histidine-rich glycoprotein associated with AMP deaminase but can internalise the plasma protein
  52. Glycosylation interference on RhoA activation: Focus on G-CSF
  53. The small peptide OGP(10-14) reduces proliferation and induces differentiation of TPO-primed M07-e cells through RhoA/TGFbeta1/SFK pathway
  54. Embedding methods for poly(l-lactic acid) microfiber mesh/human mesenchymal stem cell constructs
  55. Quantitative evaluation of myenteric ganglion cells in normal human left colon: implications for histopathological analysis
  56. PROCEEDINGS OF THE 33rd NATIONAL CONGRESS OF THE ITALIAN SOCIETY OF HISTOCHEMISTRY
  57. Morpho-Functional Characterization of Human Mesenchymal Stem Cells from Umbilical Cord Blood for Potential Uses in Regenerative Medicine
  58. Sortilin Is a Putative Postendocytic Receptor of Thyroglobulin
  59. Gelatin/PLLA Sponge-Like Scaffolds Allow Proliferation and Osteogenic Differentiation of Human Mesenchymal Stromal Cells
  60. Interaction of human gingival fibroblasts with PVA/gelatine sponges
  61. PS-341 (Bortezomib) inhibits proliferation and induces apoptosis of megakaryoblastic MO7-e cells
  62. PEG-Filgrastim activity on granulocyte functions
  63. Human autologous plasma-derived clot as a biological scaffold for mesenchymal stem cells in treatment of orthopedic healing
  64. TSH-Dependent Expression of the LDL Receptor–Associated Protein (RAP) in Thyroid Epithelial Cells
  65. Constitutive expression of cyclooxygenase-2 in the neuromuscular compartment of normal human colon
  66. Morphological features of ovine embryonic lung fibroblasts cultured on different bioactive scaffolds
  67. Glycosylated or non-glycosylated G-CSF differently influence human granulocyte functions through RhoA
  68. Kidney Expression of RhoA, TGF-β1, and Fibronectin in Human IgA Nephropathy
  69. Thyroid dysfunction in megalin deficient mice
  70. Immunohistochemical demonstration of the small GTPase RhoA on epoxy-resin embedded sections
  71. Carboxy-terminal fragment of osteogenic growth peptide regulates myeloid differentiation through RhoA
  72. Cellular and subcellular localization of the small G protein RhoA in the human and rat embryonic and adult kidney
  73. Renal cell cultures for the study of growth factor interactions underlying kidney organogenesis
  74. TGF-Alpha mRNA Expression in Renal Organogenesis: A Study in Rat and Human Embryos
  75. A morphological study of the expression of the small G protein RhoA in resting and activated MDCK cells
  76. Use of the comet test in the evaluation of multidrug resistance of human cell lines
  77. The effect of cytokines, including IL4, IL7, stem cell factor, insulin-like growth factor on childhood acute lymphoblastic leukemia
  78. GST-7T and P-170 co-expression in multiple myeloma
  79. Evaluation of resistance index of several anticancer agents on parental and resistant P-388 cell lines
  80. Induction of multidrug resistance (MDR) by transfection of MCF-10A cell line withc-Ha-ras andc-erbB-2 oncogenes
  81. Idarubicin is active on MDR cells: evaluation of DNA synthesis inhibition on P388 cell lines
  82. Vitamin D binding protein is produced by human monocytes
  83. Multidrug Resistance and Electromagnetic Fields